-A Live Webcast of the UBS Presentation will be Available on the Neovasc
VANCOUVER, Sept. 7, 2011 /CNW/ - Neovasc Inc. (TSXV: NVC), a specialty
vascular device company, today announced that senior management will
present at the upcoming 2011 Rodman and Renshaw Annual Global
Investment Conference and 2011 UBS Global Life Sciences Conference.
Neovasc chief executive officer Alexei Marko will provide an update on
recent corporate developments and expected product development
milestones. Mr. Marko and Neovasc chief financial officer Christopher
Clark will participate in post-presentation breakout sessions at the
The Neovasc Rodman and Renshaw conference presentation is scheduled for
September 13, 2011 at 2:50pm EDT. The conference is being held at the
Waldorf Astoria Hotel in New York City.
For more information about the 2011 Rodman and Renshaw Annual Global
Investment Conference, visit http://www.rodmanandrenshaw.com/conferences?id=162.
The Neovasc UBS Global Life Sciences Conference presentation is
scheduled for September 21, 2011 at 2:30pm EDT. The conference is being
held at the Grand Hyatt Hotel in New York City.
The audio portion of the company's UBS presentation will be webcast
live. It can be accessed at the Investors section of the Neovasc
website at www.neovasc.com. An archived version of the webcast will be available on the Neovasc
website for 30 days beginning about three hours after the start of the
About Neovasc Inc.
Neovasc Inc. is a specialty vascular device company that develops,
manufactures and markets medical devices for the rapidly growing
vascular and surgical marketplace. The company's current products
include the Neovasc Reducer™, an innovative product to treat refractory
angina, the Tiara™ program developing novel transcatheter technologies
for treating mitral valve disease and a line of advanced biological
tissue products that are used to enhance surgical outcomes and as key
components in a variety of third-party medical products, such as
transcatheter heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
For further information:
| Corporate contact: |
| U.S. media & investor contact: |
GendeLLindheim BioCom Partners
Barbara Lindheim or Jennifer Anderson